mRNA vaccine cuts skin cancer recurrence and death by 42% in two years
Seven years after becoming the first recipient of an mRNA vaccine designed for pancreatic cancer, Donna Gustafson shows no evidence of disease as a skin cancer trial reports a 42% reduction.